A study published in The Lancet shows the risk of breast cancer with hormone replacement therapy (HRT) in relation to the type and timing of hormonal intake.
A meta-analysis published in the Lancet this week by the Collaborative Group on Hormonal Factors in Breast Cancer reported on the risk of breast cancer with HRT in relation to the type and timing of hormonal intake.
The British Menopause Society and Royal College of Obstetricians and Gynaecologists issue a response to the findings that the effect of combined hormone replacement therapy (HRT) in increasing a woman’s risk of breast cancer is likely to have been underestimated by a number of previous studies.
The effect of combined hormone replacement therapy (HRT) in increasing a woman’s risk of breast cancer is likely to have been underestimated by a number of previous studies, according to a new prospective study published in the British Journal of Cancer.
Many women and healthcare professionals continue to be concerned about the association of HRT use and breast cancer.
Why are women misperceiving their level of risk of developing Coronary artery disease or Breast cancer?
Cheap drugs normally used to strengthen bone can cut deaths from breast cancer, research shows.
